This supports the importance of local stromal remodeling in breast cancer: hyperleptinemia can drive estrogen-dependent alterations to the TME, which can have profound effects on tumors regardless of BC hormone receptor status. This evidence concerns the gene NR4A1 and breast carcinoma.